Combined estradiol and lithium increase ER-α mRNA in embryonic C57BL/6J primary hippocampal cultures

• Autorzy: Valdes J.J. , Weeks O. I.
• Języki publikacji: EN

Abstrakty

EN

Estrogen replacement therapy (ERT) is commonly prescribed during menopause. Post-menopausal women also tend to suffer from bipolar disorders and as a result are prescribed mood stabilizers – in addition to ERT. There is a paucity of data on how combined hormones and mood stabilizers interact in regulating gene expression that led us to hypothesize that in primary cultures of mixed brain cells predominated by glia, combined 17β-estradiol (E2) and lithium chloride (LiCl) (E2/LiCl) will alter estrogen receptor-alpha (ER-α) mRNA expression. We quantified mRNA expression of ER-α using the cDNA of treated primary cultures of mixed brain cells from a previous study. Our results indicate that hippocampal cultures predominated by glia increase in ER-α mRNA expression when treated for 48 h with combined E2/LiCl. Our findings may encourage further investigation on the molecular mechanisms involved in combined estrogen and lithium treatment.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2010
• Tom: 70
• Numer: 3
• Opis fizyczny: p.297-302,fig.,ref.

Twórcy

autor

Valdes J.J.

• Department of Biological Sciences, Florida International University, Florida, USA

autor

Weeks O. I.

• Department of Biological Sciences, Florida International University, Florida, USA

Bibliografia

• Angelucci F, Aloe L, Jiménez-Vasquez P, Mathé AA (2003) Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression. Int J Neuropsychopharmacol 6: 225-231.
• Blake J (2006) Menopause: evidence-based practice. Best Pract Res Clin Obstet Gynaecol 20: 799-839.
• Burt VK, Rasgon N (2004) Special considerations in treat­ing bipolar disorder in women. Bipolar Disord 6: 2-13.
• Carbonaro V, Caraci F, Giuffrida ML, Merlo S, Canonico PL, Drago F, Copani A, Sortino MA (2009) Enhanced expres­sion of ERa in astrocytes modifies the response of cortical neurons to P-amyloid toxicity. Neurobiol Dis 33: 415-421.
• Dhandapani KM, Brann DW (2007) Role of astrocytes in estrogen-mediated neuroprotection. Exp Gerontol 42: 70-75.
• Djavadian R (2004) Serotonin and neurogenesis in the hip­pocampal dentate gyrus of adult mammals. Acta Neurobiol Exp (Wars) 64: 189-200.
• Dziedzicka-Wasylewska M, Wędzony K (1996) The effect of prolonged administration of lithium on the level of dop- amine D2 receptor mRNA in the rat striatum and nucleus accumbens. Acta Neurobiol Exp (Wars) 56: 29-34.
• Gandy S (2003) Estrogen and neurodegeneration. Neurochem Res 28: 1003-1008.
• González M, Cabrera-Socorro A, Pérez-García CG, Fraser JD, López FJ, Alonso R, Meyer G (2007) Distribution patterns of estrogen receptor alpha and beta in the human cortex and hippocampus during development and adult­hood. J Comp Neurol 503: 790-802.
• Grimes CA, Jope RS (2001) CREB DNA binding activity is inhibited by glycogen synthase kinase-3p and facilitated by lithium. J Neurochem 78: 1219-1232.
• Hongisto V, Smeds N, Brecht S, Herdegen T, Courtney MJ, Coffey ET (2003) Lithium blocks the c-Jun stress response and protects neurons via its action on glycogen synthase kinase 3. Mol Cell Biol 23: 6027-6036.
• Isgor C, Watson SJ (2005) Estrogen receptor alpha and beta mRNA expressions by proliferating and differentiating cells in the adult rat dentate gyrus and subventricular zone. Neuroscience 134: 847-856.
• Jope RS (2003) Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci 24: 441-443.
• Klein PS, Melton DA (1996) A molecular mechanism for the effect of lithium on development. PNAS 93: 8455-8459.
• Lee JM, Adeel K, Ann CP (1999) Motor neuron degenera­tion after sciatic nerve avulsion in adult rat evolves with oxidative stress and is apoptosis. J Neurobiol 40: 185­201.
• Lu YP, Zeng M, Hu XY, Xu H, Swaab DF, Ravid R, Zhou JN (2003) Estrogen receptor a-immunoreactive astro­cytes are increased in the hippocampus in Alzheimer's disease. Exp Neurol 183: 482-488.
• Manji HK, Moore GJ, Chen G (1999) Lithium at 50: have the neuroprotective effects of this unique cation been overlooked? Biol Psychiatry 46: 929-940.
• McEwen BS (2001) Genome and hormones: gender differ­ences in physiology: invited review: estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol 91: 2785-2801.
• Mitra SW, Hoskin E, Yudkovitz J, Pear L, Wilkinson HA, Hayashi S, Pfaff DW, Ogawa S, Rohrer SP, Schaeffer JM, McEwen BS, Alves SE (2003) Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha. Endocrinology 144: 2055­2067.
• Morissette M, Di Paolo T (1996) Acute effect of 170- estradiol and lithium on ovariectomized rat brain bio- genic amines metabolism. J Psychiatr Res 30: 95-107.
• Nair S, Vadlamudi RK (2007) Emerging significance of ER-coregulator PELP1/MNAR in cancer. Histol Histopathol 22: 91-6.
• Ng Y, Wolfe A, Novaira HJ, Radovick S (2009) Estrogen regulation of gene expression in GnRH neurons. Mol Cell Endocrinol 303: 25-33.
• Rune GM, Wehrenberg U, Prange-Kiel J, Zhou L, Adelmann G, Frotscher M (2002) Estrogen up-regulates estrogen receptor alpha and synaptophysin in slice cultures of rat hippocampus. Neuroscience 113: 167-175.
• Saravia F, Beauquis J, Pietranera L, De Nicola AF (2007) Neuroprotective effects of estradiol in hippocampal neu­rons and glia of middle age mice. Psychoneuroendocrinology 32: 480-492.
• Shughrue PJ, Lane MV, Merchenthaler I (1997) Comparative distribution of estrogen receptor-a and -ß mRNA in the rat central nervous system. J Comp Neurol 388: 507-525.
• Soares C, Taylor V (2007) Effects and management of the menopausal transition in women with depression and bipolar disorder. J Clin Psychiatry 68: 16-21.
• Sohrabji F, Lewis DK (2006) Estrogen-BDNF interactions: Implications for neurodegenerative diseases. Front Neuroendocrinol 27: 404-414.
• Solum DT, Handa RJ (2002) Estrogen regulates the develop­ment of brain-derived neurotrophic factor mRNA and protein in the rat hippocampus. J Neurosci 22: 2650­2659.
• Song D, Du T, Li B, Cai L, Gu L, Li H, Chen Y, Hertz L, Peng L (2008) Astrocytic alkalinization by therapeutically relevant lithium concentrations: implications for myo­inositol depletion. Psychopharmacology 200: 187-195.
• Su JD, Qiu J, Zhong YP, Li XY, Wang JW, Chen YZ (2001) Expression of estrogen receptor (ER)-alpha and -beta immunoreactivity in hippocampal cell cultures with spe­cial attention to GABAergic neurons. J Neurosci Res 65: 396-402.
• Valdes JJ, Weeks OI (2009) Estradiol and lithium chloride specifically alter NMDA receptor subunit NR1 mRNA and excitotoxicity in primary cultures. Brain Res 1268: 1-12.
• Webber K, Bowen R, Casadesus G, Perry G, Atwood C, Smith M (2004) Gonadotropins and Alzheimer's dis­ease: the link between estrogen replacement therapy and neuroprotection. Acta Neurobiol Exp (Wars) 64: 113­118.

Uwagi

PL

Rekord w opracowaniu